Previous 10 | Next 10 |
Ekso Bionics (EKSO) entered into an underwriting agreement with H.C. Wainwright & Co. to purchase on a firm commitment basis 975,610 shares at a price to the public of $10.25 per share, less underwriting discounts and commissions. Underwriter's a 30-day option to purchase up to an ad...
RICHMOND, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it has entered into an underwriting agreement with H.C. Wainwright...
Ekso Bionics (EKSO) drops 4.4% after hours on interim results and anticipates Q4 2020 sales of $2.3M, down 38% from $3.7M a year ago. Fiscal year 2020 sales is expected to be $8.9M, -36% Y/Y.Cash at December 31, 2020 was $12.9M.Q3 sales declined 13% to $2.9M though above expectation...
RICHMOND, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary top line financial results for the fourth quarter and fiscal year ended December 31, 2020....
RICHMOND, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Peurach, President & Chief Executive Officer, and Jack Glenn, Chief Financial Officer, w...
RICHMOND, Calif., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the election of Mary Ann Cloyd and Rhonda A. Wallen to its Board of Dire...
Gainers: Ocugen (OCGN) +263%, Jaguar Health (JAGX) +108%, Acasti Pharma (ACST) +61%, Scopus BioPharma (SCPS) +43%, Ekso Bionics Holdings (EKSO) +21%.Losers: Cellectar Biosciences (CLRB) -31%, CRH Medical (CRHM) -23%, CNS Pharmaceuticals (...
Lizhi (LIZI) +29%.Ekso Bionics Holdings (EKSO) +25%.AgEagle Aerial Systems (UAVS) +22%.ENGlobal Corporation (ENG) +23%.Supernus Pharmaceuticals (SUPN) +23%.Scopus BioPharma (SCPS) +21%.Mogo (MOGO) +18%.Magnite (MGNI) +18%.Kopin Corporation (KOPN) +18%.Magna International (MGA) +18%.InMed Phar...
RICHMOND, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the continued adoption of its latest industry exoskeleton innovation, EV...
Ekso Bionics Holdings, Inc. (EKSO) Q3 2020 Earnings Conference Call October 29, 2020 4:30 PM ET Company Participants David Carey - IR, Lazar Partners Ltd. Jack Peurach - President & Chief Executive Officer Bill Shaw - Chief Commercial Officer Jack Glenn - Chief Financial Officer Conferenc...
News, Short Squeeze, Breakout and More Instantly...
Ekso Bionics Holdings Inc. Company Name:
EKSO Stock Symbol:
NASDAQ Market:
Ekso Bionics Holdings Inc. Website:
SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2...
Collaboration Expands Use of EksoNR and Ekso Indego Devices in Rehabilitation and Community Settings to Better Improve Patient Quality of Life SAN RAFAEL, Calif., June 25, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso...
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso’s Board Deborah Lafer Scher SAN RAFAEL, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”...